Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 5 I, 1999, Pages 1562-1567

  Mulder, Alma ^a   Gauvreau, Gail M ^a   Watson, Rick M ^a   O'Byrne, Paul M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; LEUKOTRIENE D4; METHACHOLINE;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS BIOPSY; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; SPUTUM ANALYSIS;

EID: 0032941102     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.5.9810095     Document Type: Article

References (41)

1. Beasley, R., W. R. Roche, J. A. Roberts, and S. T. Holgate. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139:806-817.
2. Pizzichini, E., M. M. Pizzichini, A. Efthimiadis, S. Evans, M. M. Morris, D. Squillace, G. J. Gleich, J. Dolovich, and F. E. Hargreave. 1996. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am. J. Respir. Crit. Care Med. 154:308-317.
3. Pin, I., P. G. Gibson, R. Kolendowicz, A. Girgis-Gabardo, J. A. Denburg, F. E. Hargreave, and J. Dolovich. 1992. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47: 25-29.
4. Holz, O., R. A. Jorres, P. Speckin, M. Mucke, and H. Magnussen. 1998. Changes in sputum composition between two inductions performed on consecutive days. Thorax 53:83-86.
5. Kirby, J. G., F. E. Hargreave, G. J. Gleich, and P. M. O'Byrne. 1987. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am. Rev. Respir. Dis. 136:379-383.
6. Broide, D. H., G. J. Gleich, A. J. Cuomo, D. A. Coburn, E. C. Federman, L. B. Schwartz, and S. I. Wasserman. 1991. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J. Allergy Clin. Immunol. 88:637-648.
7. de Monchy, J. G., H. F. Kauffman, P. Venge, G. H. Koeter, H. M. Jansen, H. J. Sluiter, and K. de Vrics. 1985. Bronchoalveolar cosinophilia during allergen-induced late asthmatic reaction. Am. Rev. Respir. Dis. 131:373-376.
8. Gauvreau, G. M., J. Doctor, R. M. Watson, M. Jordana, and P. M. O'Byrne. 1996. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am. J. Respir. Crit. Care Med. 154: 1267-1271.
9. Kraft, M., C. M. Bettinger, S. E. Wenzel, C. G. Irvin, S. J. Ackerman, and R. J. Martin. 1995. Methacholine challenge does not affect bronchoalveolar fluid cell number and many indices of cell function in asthma. Eur. Respir. J. 8:1966-1971.
10. 4 and methacholine on sputum cell differentials in asthma. Am. J. Respir. Crit. Care Med. 155:1247-1253.
11. 4 and granulocytic infiltration into asthmatic airways. Lancet 341:989-990.
12. Drazen, J. M., and K. F. Austen. 1987. State of the art: leukotrienes and airway responses. Am. Rev. Respir. Dis. 136:985-998.
13. 4 and to methacholine in patients with asthma and normal controls. N. Engl. J. Med. 315:480-484.
14. 4 in humans. Am. Rev. Respir. Dis. 131:368-372.
15. Griffin, M., J. W. Weiss, A. G. Leitch, E. R. McFadden, Jr., E. J. Corey, K. F. Austen, and J. M. Drazen. 1983. Effects of leukolriene D on the airways in asthma. N. Engl. J. Med. 308:436-439.
16. O'Byrne, P. M., and P. J. Manning. 1992. Clinical relevance of lipid mediators in asthma. J. Asthma 29:153-163.
17. 4, increase the release of mucus from human airways in vitro. Am. Rev. Respir. Dis. 126:449-451.
18. Dahlen, S. E., J. Bjork, P. Hedqvist, K. E. Arfors, S. Hammarstrom, J. A. Lindgren, and B. Samuelsson. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. U.S.A. 78:3887-3891.
19. 4 levels during early and late asthmatic responses. J. Allergy Clin. Immunol. 86:211-220.
20. Hamilton, A. L., R. M. Watson, G. Wyile, and P. M. O'Byrne. 1997. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist BAYx1005. Thorax 52:348-354.
21. Taylor, I. K., K. M. O'Shaughnessy, R. W. Fuller, and C. T. Dollery. 1991. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 337:690-694.
22. 4 antagonist, L-648,051. Allergy 47:604-609.
23. Calhoun, W. J., B. J. Lavins, M. C. Minkwitz, R. Evans, G. J. Gleich, and J. Chon. 1998. Effect of zafirlukast (accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge. Am. J. Respir. Crit. Care Med. 157:1381-1389.
24. Nakamura, Y., M. Hoshino, J. J. Sim, K. Ishii, K. Hosaka, and T. Sakamoto. 1998. Effect of the leukolriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax 53:835-841.
25. Calhoun, W. J., K. L. Williams, S. G. Simonson, and B. J. Lavins. 1997. Effect of zafirlukast (accolate) on airway inflammation after segmental allergen challenge in patients with mild asthma (abstract). Am. J. Respir. Crit. Care Med. 155:A662.
26. Cockcroft, D. W., K. Y. Murdock, J. Kirby, and F. E. Hargreave. 1987. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am. Rev. Respir. Dis. 135:264-267.
27. O'Byrne, P. M., J. Dolovich, and F. E. Hargreave. Late asthmatic response. Am. Rev. Respir. Dis. 136:740-751.
28. Cockcroft, D. M. 1985. Measure of airway responsiveness to inhaled histamine or methacholine; method of continuous aerosol generation and tidal breathing inhalation. In F. E. Hargreave and A. J. Woolcock, editors. Airway Responsiveness: Measurement and Interpretation. Astra Pharmaceuticals Canada, Ltd., Mississauga, ON. 22-28.
29. Snedecor, G. W., and W. G. Cochran. 1989. Statistical methods, 8th ed. Iowa State University Press, Ames, IA. 55-57, 374-396.
30. Fahy, J. V., J. Liu, H. Wong, and H. A. Boushey. 1994. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J. Allergy Clin. Immunol. 93:1031-1039.
31. O'Byrne, P. M., J. G. Kirby, and F. E. Hargreave. 1987. Airway inflammation and hyperresponsiveness. Am. Rev. Respir. Dis. 136(Suppl.): S35-S37.
32. Foresi, A., C. Leone, A. Pelucchi, B. Mastropasqua, A. Chetta, R. D'Ippolito, L. Marazzini, and D. Olivieri. 1997. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness, J. Allergy Clin. Immunol. 100:58-64.
33. 4 administration in the guinea pig. Am. J. Respir. Crit. Care Med. 154: 850-857.
34. 4 in the lung. Agents Actions 13:S173-S175.
35. 4 effects on human eosinophil and neutrophil motility in vitro. J. Leukoc. Biol. 55:183-191.
36. 4 and platelet-activating factor on human alveolar macrophage eicosanoid and PAF synthesis. Am. Rev. Respir. Dis. 148:682-688.
37. Robertson, D. G., A. T. Kerigan, F. E. Hargreave, R. Chalmers, and J. Dolovich. 1974. Late asthmatic responses induced by ragweed pollen allergen. J. Allergy Clin. Immunol. 54:244-254.
38. 4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am. Rev. Respir. Dis. 142:112-119.
39. Leff, J. A., E. Pizzichini, A. Efthimiadis, L. P. Boulet, L. X. Wei, D. E. Weinland, L. Hendeles, and F. E. Hargreave. 1997. Effect of montelukast (MK-0476) on airway eosinophilic inflammation in mildly uncontrolled asthma: a randomized placebo-controlled trial (abstract). Am. J. Respir. Crit. Care Med. 155:A976.
40. 4 receptor antagonist, on allergen-induced airway responses in asthmatic subjects (abstract). Am. J. Respir. Crit. Care Med. 153:A346.
41. Reiss, T. F., C. A. Sorkness, W. Stricker, A. Botto, W. W. Busse, S. Kundu, and J. Zhang. 1997. Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticostcroids. Thorax 52:45-48.